Immuron (IMRN) Other Working Capital Changes (2020 - 2023)
Immuron (IMRN) recorded quarterly Other Working Capital Changes of -$1.7 million in Q2 2023, up 23.07% quarter-over-quarter from -$2.3 million in Q2 2022, and up 23.07% on a YoY basis from -$1.4 million in Q2 2022.
Immuron (IMRN) Other Working Capital Changes (2020 - 2023) Analysis & Trends
Immuron's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$1.7 million for Q2 2023.
- In Q2 2023, Other Working Capital Changes rose 23.07% year-over-year to -$1.7 million; the TTM figure through Jun 2023 stood at -$9.2 million (changed N/A YoY), while the FY2023 annual figure was -$1.7 million, up 23.07% from the prior year.
- Other Working Capital Changes was -$1.7 million for Q2 2023 at Immuron, up from -$2.3 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$1.7 million in Q2 2023 to a low of -$3.1 million in Q2 2021.
- Historically, Other Working Capital Changes has averaged -$2.3 million across 4 years, with a median of -$2.2 million in 2022.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes slumped 52.26% in 2021, then gained 28.22% in 2022.
- A 4-year view of Other Working Capital Changes shows it stood at -$2.1 million in 2020, then sank by 52.26% to -$3.1 million in 2021, then grew by 28.22% to -$2.3 million in 2022, then gained by 23.07% to -$1.7 million in 2023.
- The last three Other Working Capital Changes figures came in at -$1.7 million (Q2 2023), -$2.3 million (Q2 2022), and -$3.1 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.73 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Jun 30, 2022 | -2.25 Mn |
| Jun 30, 2021 | -3.14 Mn |
| Jun 30, 2021 | -3.14 Mn |
| Jun 30, 2020 | -2.06 Mn |
| Jun 30, 2020 | -2.06 Mn |